These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7717939)

  • 21. Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast.
    Schwartz GF; Cantor RI; Biermann WA
    Arch Surg; 1987 Dec; 122(12):1430-4. PubMed ID: 3689121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy.
    McIntosh SA; Ogston KN; Payne S; Miller ID; Sarkar TK; Hutcheon AW; Heys SD
    Am J Surg; 2003 Jun; 185(6):525-31. PubMed ID: 12781879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
    Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
    Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative multimodal therapy for locally advanced non-inflammatory breast cancer.
    Shanta V; Krishnamurthi S
    Clin Oncol (R Coll Radiol); 1991 May; 3(3):137-40. PubMed ID: 2069878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of inflammatory carcinoma of the breast. A combined modality approach.
    Fastenberg NA; Martin RG; Buzdar AU; Hortobagyi GN; Montague ED; Blumenschein GR; Jessup JM
    Am J Clin Oncol; 1985 Apr; 8(2):134-41. PubMed ID: 3841746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
    Sataloff DM; Mason BA; Prestipino AJ; Seinige UL; Lieber CP; Baloch Z
    J Am Coll Surg; 1995 Mar; 180(3):297-306. PubMed ID: 7874340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Romito S; Gebbia V; Pacilio G; Giotta F; Testa A; Pezzella G; Durini E; Agostara B; Cariello S
    Br J Cancer; 1995 Nov; 72(5):1245-50. PubMed ID: 7577476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
    Bonadonna G; Veronesi U; Brambilla C; Ferrari L; Luini A; Greco M; Bartoli C; Coopmans de Yoldi G; Zucali R; Rilke F
    J Natl Cancer Inst; 1990 Oct; 82(19):1539-45. PubMed ID: 2402015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of mammography in breast preservation in locally advanced breast cancer.
    Pierce L; Adler D; Helvie M; Lichter A; Merajver S
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):571-7. PubMed ID: 8621280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.
    van der Wall E; Rutgers EJ; Holtkamp MJ; Baars JW; Schornagel JH; Peterse JL; Beijnen JH; Rodenhuis S
    Br J Cancer; 1996 May; 73(9):1080-5. PubMed ID: 8624267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
    Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
    Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
    Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locally advanced breast cancer: is surgery necessary?
    Favret AM; Carlson RW; Goffinet DR; Jeffrey SS; Dirbas FM; Stockdale FE
    Breast J; 2001; 7(2):131-7. PubMed ID: 11328324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.
    Bellino R; Cortese P; Danese S; De Sanctis C; Durando A; Genta F; Grio R; Giardina G; Katsaros D; Massobrio M; Richiardi G; Vicelli R
    Anticancer Res; 2000; 20(6C):4825-8. PubMed ID: 11205227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.
    Coombes RC; Bliss JM; Wils J; Morvan F; Espié M; Amadori D; Gambrosier P; Richards M; Aapro M; Villar-Grimalt A; McArdle C; Pérez-López FR; Vassilopoulos P; Ferreira EP; Chilvers CE; Coombes G; Woods EM; Marty M
    J Clin Oncol; 1996 Jan; 14(1):35-45. PubMed ID: 8558217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B.
    Marks LB; Halperin EC; Prosnitz LR; Ross M; Vredenburgh JJ; Rosner GL; Peters W
    Int J Radiat Oncol Biol Phys; 1992; 23(5):1021-6. PubMed ID: 1639635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy.
    Vlastos G; Mirza NQ; Lenert JT; Hunt KK; Ames FC; Feig BW; Ross MI; Buzdar AU; Singletary SE
    Cancer; 2000 Mar; 88(6):1417-24. PubMed ID: 10717625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.